Bleeker, NL
Arno Bleeker, Westerhoven NL
Patent application number | Description | Published |
---|---|---|
20090033893 | Methods and Systems to Compensate for a Stitching Disturbance of a Printed Pattern in a Maskless Lithography System Not Utilizing Overlap of the Exposure Zones - A method and system are provided for forming a pattern within an area of a photosensitive surface. An exemplary method includes performing a first exposure of the photosensitive surface in accordance with predetermined image data, wherein the first exposure occurs during a first pass and produces a first image within the area. The image data is adjusted to compensate for identified image deficiencies image deficiencies, the image deficiencies being within a region of the first image. A second exposure, of the photosensitive surface, is performed in accordance with the adjusted image data during a second pass. | 02-05-2009 |
Jean Bart Bleeker, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20150338119 | EVAPORATIVE HUMIDIFIER AND INDOOR CLIMATE CONTROLLING SYSTEM COMPRISING THE SAME - The invention relates to an evaporative humidifier including a water reservoir, a wick unit and a fan unit. The wick unit is configured to absorb water from the water reservoir. The fan unit is arranged within a fan housing and configured to force an air flow to flow through the wick unit. The fan housing comprises a top cover unit defining at least one annular air outlet at an outer part adjacent a circumference of the top cover unit. One of the main advantages of this invention is that the evaporative humidifier has an optimal air flow path and can operate in a low noise. The invention also relates to an indoor climate controlling system using such an evaporative humidifier. | 11-26-2015 |
Jean Bart Bleeker, Hoogeveen NL
Patent application number | Description | Published |
---|---|---|
20090183639 | METHOD FOR CONTROLLING A QUANTITY OF WATER TO BE USED FOR THE PURPOSE OF OBTAINING A QUANTITY OF HOT LIQUID - A beverage maker ( | 07-23-2009 |
Laurence Jeroen Bleeker, Dronten NL
Patent application number | Description | Published |
---|---|---|
20120123047 | RESIN COMPOSITION - The present invention relates to a resin composition comprising (a) from 30 to 80 wt. % of an unsaturated polyester resin and/or a vinyl ester resin and (b) from 10 to 50 wt. % of styrene, wherein the resin composition further comprises (c) an ester of itaconic acid and (d) a paraffin oil and/or a paraffin wax. | 05-17-2012 |
Michel Bleeker, Eindhoven NL
Patent application number | Description | Published |
---|---|---|
20100055403 | METHOD FOR MANUFACTURING A HOUSING ELEMENT HAVING A DECORATIVE COVERING AND A GRIP LAYER - A housing element ( | 03-04-2010 |
Michel Bleeker, Groningen NL
Patent application number | Description | Published |
---|---|---|
20090047854 | METHOD OF MANUFACTURING A PRODUCT PART BY USING A COMPOSITE FIBRE SHEET AND APPLYING PLASTIC TO THIS SHEET - In a process of manufacturing a product part ( | 02-19-2009 |
20090320297 | GRIP | 12-31-2009 |
Petronella Martina Bleeker, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20110113512 | TRICHOME SPECIFIC PROMOTERS - Trichome specific plant promoters are provided herein. Also provided are transgenic cells and organisms, especially plant cell and plants, comprising an trichome specific promoter and methods for expressing nucleic acid sequences in cells and organisms using trichome specific promoters. | 05-12-2011 |
20120087889 | PLANT VOLATILES BASED ON R-CURCUMENE - The invention provides a method for controlling whiteflies which comprises the steps of: providing a composition comprising or consisting of R-curcumene and optionally further beta-myrcene, para-cymene, gamma-terpinene, alpha-terpinene, alpha-phellandrene zingiberene and/or 7-epi-zingiberene; and adding said composition one or more times to a plurality of crop plants. The method can be combined with the use of attractant compositions comprising beta-phellandrene, limonene and/or 2-carene, and optionally adding said composition one or more times to one or more trap plants and/or trap materials. | 04-12-2012 |
Petronella Martina Bleeker, Dc Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20120076751 | PLANT VOLATILES - The present invention provides compounds and compositions for attracting or repelling sap-sucking insects, such as whitefly, as well as methods for using such compositions. | 03-29-2012 |
Petronella Martina Bleeker, Wageningen NL
Patent application number | Description | Published |
---|---|---|
20140157456 | PEST RESISTANT PLANTS - The disclosure provides an isolated nucleic acid molecule encoding a 7-epizingiberene synthase, a chimeric gene comprising said nucleic acid molecule, vectors comprising the same, as well as isolated 7-epizingiberene synthase proteins themselves. In addition, transgenic plants and plant cells comprising a gene encoding a 7-epizingiberene synthase, optionally integrated in its genome, and methods for making such plants and cells, are provided. Especially Solanaceae plants and plant parts (seeds, fruit, leaves, etc.) with enhanced insect pest resistance are provided. | 06-05-2014 |
20150101084 | PEST RESISTANT PLANTS - The disclosure provides an isolated nucleic acid molecule encoding a 7-epizingiberene synthase, a chimeric gene comprising said nucleic acid molecule, vectors comprising the same, as well as isolated 7-epizingiberene synthase proteins themselves. In addition, transgenic plants and plant cells comprising a gene encoding a 7-epizingiberene synthase, optionally integrated in its genome, and methods for making such plants and cells, are provided. Especially Solanaceae plants and plant parts (seeds, fruit, leaves, etc.) with enhanced insect pest resistance are provided. | 04-09-2015 |
Robert Bleeker, Beverwijk NL
Patent application number | Description | Published |
---|---|---|
20090297881 | STEEL SHEET WITH HOT DIP GALVANIZED ZINC ALLOY COATING AND PROCESS TO PRODUCE IT - Steel strip provided with a hot dip galvanized zinc alloy coating layer, in which the coating of the steel strip is carried out in a bath of molten zinc alloy, the zinc alloy in the coating consisting of: 0.3-2.3 weight % magnesium; 0.6-2.3 weight % aluminium; optional <0.2 weight % of one or more additional elements; unavoidable impurities; the remainder being zinc in which the zinc alloy coating layer has a thickness of 3-12 μm. | 12-03-2009 |
20140302343 | STEEL SHEET WITH HOT DIP GALVANIZED ZINC ALLOY COATING AND PROCESS TO PRODUCE IT - Steel strip provided with a hot dip galvanized zinc alloy coating layer, in which the coating of the steel strip is carried out in a bath of molten zinc alloy, the zinc alloy in the coating of: 0.3-2.3 weight % magnesium; 0.6-2.3 weight % aluminium; optional <0.2 weight % of one or more additional elements; unavoidable impurities; the remainder being zinc in which the zinc alloy coating layer has a thickness of 3-12 μm. | 10-09-2014 |
Willem Karel Bleeker, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20100255012 | RECOMBINANT FUCOSE MODIFIED MONOVALENT HALF-ANTIBODIES OBTAINED BY MOLECULAR ENGINEERING - Glycosylated monovalent antibodies binding to selected antigens with a low or lacking fucose content, which are capable of inducing antibody dependent cellular cytotoxicity (ADCC) on cells expressing the selected antigens in the presence of effector cells, methods for producing the monovalent antibodies, pharmaceutical compositions comprising such monovalent antibodies and use thereof for different diagnostic and therapeutic applications. | 10-07-2010 |
20100291023 | METHOD FOR EXTENDING THE HALF-LIFE OF EXOGENOUS OR ENDOGENOUS SOLUBLE MOLECULES - The present invention relates to methods for extending the in vivo half-life of an exogenous soluble therapeutic molecule administered to a subject, by administering to said subject the exogenous soluble molecule and a monovalent antibody that binds to the exogenous soluble molecule, as well as method for treating a disease or disorder associated with an insufficient level of an endogenous soluble molecule in a subject, by administering to said subject a monovalent antibody that binds to the endogenous soluble molecule. | 11-18-2010 |
20100306867 | TRANSGENIC ANIMALS PRODUCING MONOVALENT HUMAN ANTIBODIES AND ANTIBODIES OBTAINABLE FROM THESE ANIMALS - The invention relates to novel non-human transgenic animals, which upon antigenic stimulation are capable of producing monovalent antibodies binding to a selected antigen, modified heavy chain transgenes, methods for producing the non-human transgenic animals, methods for immunizing the non-human transgenic animals for as well as monovalent antibodies obtainable by such immunization methods. | 12-02-2010 |
20100325744 | NON-GLYCOSYLATED RECOMBINANT MONOVALENT ANTIBODIES - The present invention provides non-glycosylated monovalent antibodies with a long half-life when administered in vivo, methods of making such monovalent antibodies, pharmaceutical compositions comprising such antibodies, and uses of the monovalent antibodies. | 12-23-2010 |
20110045007 | FUSION OR LINKED PROTEINS WITH EXTENDED HALF LIFE - The present invention provides fusion proteins comprising a first molecule, and a second molecule which is a monovalent immunoglobulin or a fragment of a monovalent immunoglobulin with a long half-life when administered in vivo, methods of making such fusion proteins, pharmaceutical compositions comprising such fusion proteins, and uses thereof. | 02-24-2011 |
20110256142 | NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER - The invention relates to novel methods for the treatment of tumors, comprising administration of a bispecific antibody or a combination of two or more non-cross-blocking antibodies that recognize the same target antigen or antigenic complex. In particular, the invention relates to a method for inducing complement-mediated cell killing in the treatment of a tumor, said method comprising combined administration, to a human being in need thereof, of a first antibody and a second antibody, wherein—said first antibody binds EGFR, —said second antibody binds EGFR, —said first and second antibody are non-cross-blocking, and—the dosage regimen is such that CDC is obtained at the tumor site. | 10-20-2011 |
20110300156 | HUMAN ANTIBODIES AGAINST TISSUE FACTOR - Isolated human monoclonal antibodies which bind to human TF and related antibody-based compositions and molecules, are disclosed. Also disclosed are pharmaceutical compositions comprising the antibodies, and therapeutic and diagnostic methods for using the antibodies. | 12-08-2011 |
20140030273 | HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74 - Isolated human monoclonal antibodies which bind to human CD74 and related antibody-drug conjugates are disclosed. Pharmaceutical compositions comprising the antibodies or antibody-drug conjugates, and therapeutic and diagnostic methods for using the antibodies and/or antibody-drug conjugates, are also disclosed. | 01-30-2014 |
20140348833 | NOVEL METHODS AND ANTIBODIES FOR TREATING CANCER - The invention relates to novel methods for the treatment of tumors, comprising administration of a bispecific antibody or a combination of two or more non-cross-blocking antibodies that recognize the same target antigen or antigenic complex. In particular, the invention relates to a method for inducing complement-mediated cell killing in the treatment of a tumor, said method comprising combined administration, to a human being in need thereof, of a first antibody and a second antibody, wherein | 11-27-2014 |
Wim Bleeker, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20130101608 | HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR - Antibody drug conjugates against tissue factor. Also disclosed are pharmaceutical compositions comprising the antibodies and antibody drug conjugates, and therapeutic and diagnostic methods for using the antibodies and antibody drug conjugates. | 04-25-2013 |